Bicara Therapeutics Inc.
BCAX
34 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Nov 24 9:10 PM | Hyep Ivan | Proposed Sale | 17,795 | $18.55 | $330.1K | — | View → |
| Nov 24, 2025 | Nov 24 9:09 PM | Raben David | Proposed Sale | 5,500 | $18.45 | $101.5K | — | View → |
| Nov 21, 2025 | Nov 21 9:33 PM | Hyep Ivan | Proposed Sale | 605 | $18.15 | $11.0K | — | View → |
| Nov 21, 2025 | Nov 21 9:32 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.05 | $225.6K | — | View → |
| Oct 16, 2025 | Oct 16 8:13 PM | Mazumdar Claire | Proposed Sale | 24,103 | $18.83 | $453.8K | — | View → |
| Oct 15, 2025 | Oct 15 8:20 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.13 | $226.6K | — | View → |
| Oct 15, 2025 | Oct 15 8:18 PM | Mazumdar Claire | Proposed Sale | 13,289 | $18.84 | $250.4K | — | View → |
| Oct 13, 2025 | Oct 14 1:05 PM | Mazumdar Claire | Proposed Sale | 11,445 | $18.92 | $216.5K | — | View → |
| Oct 9, 2025 | Oct 9 8:31 PM | Hyep Ivan | Proposed Sale | 6,415 | $17.89 | $114.8K | — | View → |
| Oct 9, 2025 | Oct 9 8:08 PM | Raben David | Proposed Sale | 22,000 | $18.45 | $405.9K | — | View → |
| Oct 8, 2025 | Oct 8 8:04 PM | Hyep Ivan | Proposed Sale | 5,627 | $18.17 | $102.2K | — | View → |
| Oct 7, 2025 | Oct 7 8:20 PM | Hyep Ivan | Proposed Sale | 18,244 | $18.00 | $328.4K | — | View → |
| Oct 7, 2025 | Oct 7 8:07 PM | Cohlhepp Ryan | Proposed Sale | 10,900 | $18.00 | $196.2K | — | View → |
| Oct 6, 2025 | Oct 6 8:36 PM | Cohlhepp Ryan | Proposed Sale | 39,600 | $18.06 | $715.0K | — | View → |
| Oct 6, 2025 | Oct 6 8:07 PM | Hyep Ivan | Proposed Sale | 6,514 | $17.04 | $111.0K | — | View → |
| Sep 29, 2025 | Sep 29 8:38 PM | LARA MEISNER | Proposed Sale | 33,807 | $11.71 | $395.9K | — | View → |
| Jun 16, 2025 | Jun 16 8:29 PM | LARA S. MEISNER | Proposed Sale | 31,658 | $10.84 | $343.2K | — | View → |
| Mar 14, 2025 | Mar 14 8:21 PM | LARA S. MEISNER | Proposed Sale | 79,146 | $13.35 | $1.1M | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,499 | $3.79 | 184,608(D) | View → |
| Mar 16, 2026 | Mar 17 9:36 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 117,334(D) | View → |
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 36,766 | $3.79 | 191,107(D) | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 3,817 | $3.79 | 227,873(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,786 | $3.79 | 231,690(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 2,631 | $3.79 | 233,476(D) | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Option Exercise | 12,892 | $3.79 | 125,334(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 2,963 | $3.79 | 79,784(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 13,555 | $3.79 | 82,747(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 16,300 | $3.79 | 52,913(D) | View → |
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 200 | $3.79 | 69,213(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,200,000 | $0.0001 | 2,200,000(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 3,108 | $3.79 | 138,226(D) | View → |
| Feb 2, 2026 | Feb 4 9:38 PM | Ryan CohlheppDirector, President and COO | Grant/Award | 300,000 | $16.76 | 300,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:37 PM | Claire MazumdarDirector, Chief Executive Officer | Grant/Award | 450,000 | $16.76 | 450,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:36 PM | David RabenChief Medical Officer | Grant/Award | 100,000 | $16.76 | 100,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:35 PM | Ivan HyepChief Financial Officer | Grant/Award | 125,000 | $16.76 | 125,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:34 PM | Lara MeisnerChief Legal Officer | Grant/Award | 90,000 | $16.76 | 90,000(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Option Exercise | 1,882 | $3.79 | 65,462(D) | View → |
← Previous
Page 2 of 2